It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.

Published Date: 28 Jun 2023

Physicians can personalize dosing intervals and significantly enhance patient outcomes by tracking early-response biomarkers in men receiving 177Lu-PSMA prostate cancer therapy.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

I Was Told I Had 6 Months to Live. That Was 20 Years Ago.

2.

Glofitamab Regimen Improves Survival in DLBCL

3.

Scientists hail the cervical cancer treatment as the most remarkable breakthrough in 20 years.

4.

Sarah Ferguson was identified as having malignant melanoma. These are the most recent therapies.

5.

Gatekeeping May Reduce Pediatric Cancer Trial Participation


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot